HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Cover Story

Oncologists must be ‘very cautious’ as liquid biopsy use expands


Will liquid biopsies be used routinely to screen for cancer?


Genetic anticipation and mentorship

Derek Raghavan, MD, PhD

Advanced Practice

CAR T-cell therapy for children: Meeting patient and family needs

Colleen Callahan, MSN, RN, CRNP; Amy Barry, MSN, RN, PPCNP-BC; Diane Baniewicz, MSN, RN, CRNP


‘Pen’ enables surgeons to quickly pinpoint cancerous tissue

Meeting News

Mosunetuzumab induces remissions in advanced non-Hodgkin lymphoma after CAR-T fails

BCMA-directed CAR-T induces early, deep responses in advanced multiple myeloma

‘Microvasculature on a chip’ may improve understanding of blood clots, therapy response

Oral arginine therapy appears safe, effective for sickle cell disease pain management

Front-line acalabrutinib regimen appears safe, induces complete response in chronic lymphocytic leukemia

Anastrozole provides long-term preventive effect for postmenopausal women at high risk for breast cancer

Atezolizumab fails to improve response in triple-negative breast cancer

Extended adjuvant letrozole improves DFS among certain postmenopausal women with breast cancer

Margetuximab extends survival in relapsed HER2-positive metastatic breast cancer

In the Journals

Black, Hispanic populations underrepresented in trials supporting FDA cancer drug approvals

Trifluridine and tipiracil safe, effective for pretreated metastatic gastric cancer regardless of prior gastrectomy

PTSD may increase risk for ovarian cancer

FDA News

FDA fast tracks nanatinostat combination for Epstein-Barr virus-associated lymphoma

FDA approves Brukinsa for relapsed or refractory mantle cell lymphoma

FDA approves Oxbryta for sickle cell disease

FDA grants priority review to pemigatinib for cholangiocarcinoma

Roswell Park professor promoted to chief of breast pathology

Cleveland Clinic appoints breast medical oncology director

ASH elects three to leadership positions